Concepedia
Statistics
Publications
29
Citations
2.1K
H-Index
26
Active since
1987
Affiliations
Virginia Mason Medical Center(Current)
Vanderbilt University
University of Alabama at Birmingham
University of Florida
Nexen (Canada)
Hazel B. Breitz is an author at Virginia Mason Medical Center specializing in medicine, oncology, and radionuclide therapy.
Publications per year
1987–2010
Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer.
SJ Knox, Michael L. Goris, Margaret A. Tempero et al. · PubMed · 2000 · 212 citations
Medicine, Oncology, Pharmacology +12
MIRD Pamphlet No. 20: The Effect of Model Assumptions on Kidney Dosimetry and Response—Implications for Radionuclide Therapy
Barry W. Wessels, Mark Konijnenberg, Roger Dale et al. · Journal of Nuclear Medicine · 2008 · 190 citations · Full text
Medicine, Nuclear Medicine, Radiation Oncology +17
Phase 1 trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphoma
Andres Forero, Paul L. Weiden, Julie M. Vose et al. · Blood · 2004 · 152 citations · Full text
Medicine, Immunology, Oncology +13
Clinical optimization of pretargeted radioimmunotherapy with antibody-streptavidin conjugate and 90Y-DOTA-biotin.
Hazel B. Breitz, Paul L. Weiden, Paul L. Beaumier et al. · PubMed · 2000 · 151 citations
Medicine, Nuclear Medicine, Oncology +17
Pretargeted Radioimmunotherapy (PRIT™) for Treatment of Non-Hodgkin's Lymphoma (NHL): Initial Phase I/II Study Results
Paul L. Weiden, Hazel B. Breitz, Oliver W. Press et al. · Cancer Biotherapy and Radiopharmaceuticals · 2000 · 137 citations
Medicine, Oncology, Pharmacokinetics +17
1–5 of 29